HVR Cardio Raised $11.1M in Series B Financing

HVR Cardio, an Espoo, Finland-based cardiovascular gadget firm, raised $11.1M in Series B funding.

The spherical was led by Innovestor Life Science Fund and Tesi.

The firm intends to make use of the funds to speed up progress and develop operations.

Led by Tom Fleming, CEO, and Tim Girton, CTO, HVR Cardio is growing expertise for transcatheter mitral valve restore with its CathHELIX™ Annuloplasty System, to be used by Structural Heart Physicians to deal with mitral regurgitation (MR). The CathHELIX gadget is an investigational expertise and isn’t authorized or cleared to be used in sufferers in any geography



Leave a Comment